Quadrature Capital’s OptimizeRx OPRX Stock Holding History

Quadrature Capital’s Portfolio OPRX Stock Details OPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$147K	Buy	+25,643	New	+$147K	﹤0.01%	1419
2024 Q3	–	Sell	-17,732	Closed	-$177K	–	1260
2024 Q2	$177K	Buy	+17,732	New	+$195K	﹤0.01%	971
2023 Q4	–	Sell	-20,916	Closed	-$162K	–	1332
2023 Q3	$162K	Buy	+20,916	New	+$228K	﹤0.01%	885
2023 Q2	–	Sell	-25,445	Closed	-$373K	–	1155
2023 Q1	$373K	Buy	+25,445	New	+$426K	0.01%	626
2022 Q4	–	Sell	-39,855	Closed	-$591K	–	1063
2022 Q3	$591K	Buy	+39,855	New	+$788K	0.02%	475
2022 Q2	–	Sell	-19,245	Closed	-$726K	–	899
2022 Q1	$726K	Buy	+19,245	New	+$852K	0.03%	317
2021 Q3	–	Sell	-21,650	Closed	-$1.34M	–	933
2021 Q2	$1.34M	Buy	21,650 +2,752	+15%	+$140K	0.05%	255
2021 Q1	$920K	Buy	18,898 +4,517	+31%	+$218K	0.04%	332
2020 Q4	$449K	Buy	+14,381	New	+$352K	0.02%	517

Other funds holding OPRX

WCA

Whetstone Capital Advisors Shawnee Mission, Kansas $380M AUM 20.01% 1-Year Est. Return

Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

KCM

Kennedy Capital Management St Louis, Missouri $5.65B AUM 61.31% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return

William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

PHP

Parkman Healthcare Partners Stamford, Connecticut $977M AUM 110.37% 1-Year Est. Return

Quadrature Capital's OPRX Position: Q2 2026 in Review

Quadrature Capital opened a new position in OptimizeRx (OPRX) in Q2 2026: 25,643 shares worth $147K. The stake represents ﹤0.01% of the portfolio and ranks #1419 among its holdings. This is a return to the name: Quadrature Capital previously reported a position in OPRX as recently as Q2 2024.

Quadrature Capital first reported a position in OPRX in Q4 2020 and has held it in 9 quarters since. The position peaked at $1.34M in Q2 2021. 112 funds tracked by Wall St. Rank hold OPRX as of Q2 2026.

Quadrature Capital held 25,643 shares of OptimizeRx worth $147K as of Q2 2026.
OptimizeRx was a new Quadrature Capital position in Q2 2026.
OptimizeRx made up ﹤0.01% of Quadrature Capital's portfolio in Q2 2026, its #1419 holding.
Quadrature Capital first reported a position in OptimizeRx in Q4 2020 and has held it in 9 quarters since.
Quadrature Capital's OptimizeRx position peaked at $1.34M in Q2 2021.
112 funds tracked by Wall St. Rank held OptimizeRx as of Q2 2026.

Based on Quadrature Capital's 13F filing for Q2 2026, filed 7 Aug 2026.